tradingkey.logo
tradingkey.logo
Suchen

Sanara Medtech Inc

SMTI
Zur Watchlist hinzufügen
24.840USD
+0.570+2.35%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
227.66MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Sanara Medtech Inc Unternehmen

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Inc Informationen

BörsenkürzelSMTI
Name des UnternehmensSanara Medtech Inc
IPO-datumApr 07, 1994
CEOMuppalla (Suresh V)
Anzahl der mitarbeiter141
WertpapierartOrdinary Share
GeschäftsjahresendeApr 07
Addresse1200 Summit Avenue
StadtFORT WORTH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl76102
Telefon18175292300
Websitehttps://sanaramedtech.com/
BörsenkürzelSMTI
IPO-datumApr 07, 1994
CEOMuppalla (Suresh V)

Führungskräfte von Sanara Medtech Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Sanara Medtech Inc?

Die fünf größten Anteilseigner von Sanara Medtech Inc sind: Mr. Seth D. Yon

Wie viele Institutionen halten Anteile an Sanara Medtech Inc (SMTI)?

Mit Stand vom 2026Q1 halten 131 Institutionen Anteile an Sanara Medtech Inc, mit einem Gesamtmarktwert von etwa 1.42M, was 15.50% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -599767.00 gestiegen.

Was ist die größte Einnahmequelle von Sanara Medtech Inc?

Am 2026Q1 erzielte das Geschäft mit Soft tissue repair products für Sanara Medtech Inc den höchsten Umsatz in Höhe von 91.35M, was 88.59% des Gesamtumsatzes entspricht.